Status:
UNKNOWN
The Contribution of Melatonin Vs. Placebo in Benzodiazepine Withdrawal in Methadone Maintenance Treatment Patients
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Benzodiazepines
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
We hypothesized that patient will success in benzodiazepine withdrawal if they get melatonin to solve sleep-problems which commonly occur during benzodiazepine withdrawal. Former heroin addicts, curre...
Detailed Description
A total of 100 patients will participate. Follow-up of benzodiazepines in urine after study and 6 months later will be evaluated, as well as sleep quality (using PSQI)
Eligibility Criteria
Inclusion
- Former opiates addicts, currently in methadone maintenance treatment, and abusing benzodiazepines who intend to withdrawal
- adults (\>=18y)
Exclusion
- non abusing benzodiazepine
- Refuse making benzodiazepines withdrawal
- non methadone maintenance treatment patients
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00261183
Start Date
December 1 2004
End Date
December 1 2006
Last Update
December 2 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaul Schreiber
Tel Aviv, Israel